Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
When you choose EndoTool from Monarch Medical Technologies, you receive a true partner in inpatient glucose management. EndoTool’s comprehensive support measures ensure your team is always equipped to deliver the best patient care.
24/7 assistance
Our support team is available 24/7/365 to provide the technical and clinical guidance your team needs to navigate EndoTool’s dosing recommendations with confidence. This continuous support is available to all EndoTool customers at no additional cost for the lifetime of your contract.
Dedicated support
As an EndoTool customer, you’ll have the ongoing support of your own dedicated clinician and customer success manager. They will be your consistent point of contact, helping you achieve patient safety targets, improve workflows, and optimize your use of EndoTool.
Ongoing education
Effective staff education is crucial for improving compliance with insulin management protocols. Our training strategy focuses on building and continually advancing your clinical team's knowledge of EndoTool operation. We offer onsite, hands-on training as well as remote training and eLearning modules compatible with your LMS system.
Customer success story
Sandy Fogel, MD, FACS | Carilion Clinic
Support by professionals in the field
Nurses
Providers
Diabetes educators
IT specialists
Clinical leadership
Quality assurance
Real world results
Webinars
Why Every Health System Should Use Patient-Specific Insulin Dosing Software
Join healthcare leaders from Atrium Health, CaroMont Regional Medical Center, Temple University Hospital, and Trinity Health for an in-depth panel discussion on the benefits of patient-specific insulin dosing technology.
Customer Stories
Trinity Health’s 18-Year Journey with EndoTool
Achieving near-elimination of severe hypoglycemia.
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
"*" indicates required fields